These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12204476)

  • 1. Synthesis and structure-activity relationships of new arylpiperazines: para substitution with electron-withdrawing groups decrease binding to 5-HT(1A) and D(2A) receptors.
    Santana L; Uriarte E; Fall Y; Teijeira M; Terán C; García-Martínez E; Tolf BR
    Eur J Med Chem; 2002 Jun; 37(6):503-10. PubMed ID: 12204476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and pharmacological evaluation of 1-[(1,2-diphenyl-1H-4-imidazolyl)methyl]-4-phenylpiperazines with clozapine-like mixed activities at dopamine D(2), serotonin, and GABA(A) receptors.
    Asproni B; Pau A; Bitti M; Melosu M; Cerri R; Dazzi L; Seu E; Maciocco E; Sanna E; Busonero F; Talani G; Pusceddu L; Altomare C; Trapani G; Biggio G
    J Med Chem; 2002 Oct; 45(21):4655-68. PubMed ID: 12361392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New arylpiperazine derivatives with high affinity for alpha1A, D2 and 5-HT2A receptors.
    González-Gómez JC; Santana L; Uriarte E; Brea J; Villazón M; Loza MI; De Luca M; Rivas ME; Montenegro GY; Fontenla JA
    Bioorg Med Chem Lett; 2003 Jan; 13(2):175-8. PubMed ID: 12482418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationships of a new model of arylpiperazines. 5. Study of the physicochemical influence of the pharmacophore on 5-HT(1a)/alpha(1)-adrenergic receptor affinity: synthesis of a new derivative with mixed 5-HT(1a)/d(2) antagonist properties.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Porras E; Orensanz L; Beneytez ME; Manzanares J; Fuentes JA
    J Med Chem; 2001 Jan; 44(2):186-97. PubMed ID: 11170628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New 3-benzisothiazolyl and 3-benzisoxazolylpiperazine derivatives with atypical antipsychotic binding profile.
    Orjales A; Mosquera R; Toledo A; Pumar C; Labeaga L; Innerárity A
    Eur J Med Chem; 2002 Sep; 37(9):721-30. PubMed ID: 12350289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New pyridobenzodiazepine derivatives: modifications of the basic side chain differentially modulate binding to dopamine (D(4.2), D(2L)) and serotonin (5-HT(2A)) receptors.
    Liégeois JF; Eyrolles L; Ellenbroek BA; Lejeune C; Carato P; Bruhwyler J; Géczy J; Damas J; Delarge J
    J Med Chem; 2002 Nov; 45(23):5136-49. PubMed ID: 12408724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-affinity relationship studies on D-2/5-HT1A receptor ligands. 4-(2-Heteroarylethyl)-1-arylpiperazines.
    Dukić S; Vujović M; Soskić V; Joksimović J
    Arzneimittelforschung; 1997 Mar; 47(3):239-43. PubMed ID: 9105540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed 5-HT1A/D-2 activity of a new model of arylpiperazines: 1-aryl-4-[3-(1,2-dihydronaphthalen-4-yl)-n-propyl]piperazines. 1. Synthesis and structure-activity relationships.
    Perrone R; Berardi F; Colabufo NA; Tortorella V; Fiorentini F; Olgiati V; Vanotti E; Govoni S
    J Med Chem; 1994 Jan; 37(1):99-104. PubMed ID: 8289207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of mixed D2/5-HT1A activity of N-heteroarylmethyl-N-phenylpiperazines, N-heteroarylethyl-N-phenylpiperazines and N-heteroarylpropyl-N-phenylpiperazines.
    Roglić G; Dukić-Stefanović S; Andrić D; Kostić-Rajacić S; Soskić V
    Pharmazie; 2001 Oct; 56(10):803-7. PubMed ID: 11683128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active conformation of some arylpiperazine postsynaptic 5-HT(1A) receptor antagonists.
    Paluchowska MH; Bojarski AJ; Charakchieva-Minol S; Wesołowska A
    Eur J Med Chem; 2002 Apr; 37(4):273-83. PubMed ID: 11960662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New 1-aryl-4-(biarylmethylene)piperazines as potential atypical antipsychotics sharing dopamine D(2)-receptor and serotonin 5-HT(1A)-receptor affinities.
    Feenstra RW; de Moes J; Hofma JJ; Kling H; Kuipers W; Long SK; Tulp MT; van der Heyden JA; Kruse CG
    Bioorg Med Chem Lett; 2001 Sep; 11(17):2345-9. PubMed ID: 11527728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between low/high affinity ratios for 5-HT(1A) receptors and intrinsic activity.
    Assié MB; Cosi C; Koek W
    Eur J Pharmacol; 1999 Dec; 386(1):97-103. PubMed ID: 10611469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of several substituted phenylpiperazines behaving as mixed D2/5HT1A ligands.
    Dukić S; Kostić-Rajacić S; Dragović D; Soskić V; Joksimović J
    J Pharm Pharmacol; 1997 Oct; 49(10):1036-41. PubMed ID: 9364416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel class of arylpiperazines containing N-acylated amino acids: their synthesis, 5-HT1A, 5-HT2A receptor affinity, and in vivo pharmacological evaluation.
    Zajdel P; Subra G; Bojarski AJ; Duszyńska B; Tatarczyńska E; Nikiforuk A; Chojnacka-Wójcik E; Pawłowski M; Martinez J
    Bioorg Med Chem; 2007 Apr; 15(8):2907-19. PubMed ID: 17321139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
    Bojarski AJ; Paluchowska MH; Duszyńska B; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
    Bioorg Med Chem; 2005 Mar; 13(6):2293-303. PubMed ID: 15727878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of a new model of arylpiperazines. Study of the 5-HT(1a)/alpha(1)-adrenergic receptor affinity by classical hansch analysis, artificial neural networks, and computational simulation of ligand recognition.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Rosado ML; Pardo L; Schaper K
    J Med Chem; 2001 Jan; 44(2):198-207. PubMed ID: 11170629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro and in vivo functional studies of ortho-substituted phenylpiperazine and N-substituted 4-N-(o-methoxyphenyl)aminopiperidine analogues of WAY100635.
    Mensonides-Harsema MM; Liao Y; Böttcher H; Bartoszyk GD; Greiner HE; Harting J; de Boer P; Wikström HV
    J Med Chem; 2000 Feb; 43(3):432-9. PubMed ID: 10669570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation.
    Fiorino F; Perissutti E; Severino B; Santagada V; Cirillo D; Terracciano S; Massarelli P; Bruni G; Collavoli E; Renner C; Caliendo G
    J Med Chem; 2005 Aug; 48(17):5495-503. PubMed ID: 16107148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-cinnamyl-4-(2-methoxyphenyl)piperazines: synthesis, binding properties, and docking to dopamine (D(2)) and serotonin (5-HT(1A)) receptors.
    Penjisević J; Sukalović V; Andrić D; Kostić-Rajacić S; Soskić V; Roglić G
    Arch Pharm (Weinheim); 2007 Sep; 340(9):456-65. PubMed ID: 17763374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD 158771, a potential antipsychotic agent with D(2)/D(3) partial agonist and 5-HT(1A) agonist actions. I. Neurochemical effects.
    Akunne HC; Zoski KT; Davis MD; Cooke LW; Meltzer LT; Whetzel SZ; Shih YH; Wustrow DJ; Wise LD; MacKenzie RG; Georgic LM; Heffner TG; Pugsley TA
    Neuropharmacology; 2000 Apr; 39(7):1197-210. PubMed ID: 10760362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.